Oncoinvent ASA (OSL:ONCIN)
Norway · Delayed Price · Currency is NOK 45.90
-0.10 (-0.21%)
Mar 30, 2026, 1:59 PM CET
Oncoinvent ASA Market Cap
Oncoinvent ASA has a market cap or net worth of 205.98 million as of March 30, 2026.
Market Cap
205.98M
Enterprise Value
136.81M
Revenue
20.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
45.90
Market Cap Chart
Since October 30, 2025, Oncoinvent ASA's market cap has increased from 186.40M to 205.98M, an increase of 10.51%. That is a compound annual growth rate of 27.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 205.98M | -6.32% |
| Dec 30, 2025 | 219.89M | 17.96% |
| Oct 30, 2025 | 186.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 1.73B |
| Thor Medical ASA | 1.63B |
| Nykode Therapeutics AS | 1.01B |
| ArcticZymes Technologies ASA | 990.78M |
| Lytix Biopharma AS | 772.85M |
| Zelluna ASA | 506.85M |
| SoftOx Solutions AS | 183.14M |
| EXACT Therapeutics AS | 120.20M |